SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-043231
Filing Date
2019-11-13
Accepted
2019-11-13 16:11:51
Documents
71
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 ALT Q3 2019 10-Q alt-10q_20190930.htm 10-Q 1967278
2 EX-10.2 alt-ex102_354.htm EX-10.2 134125
3 EX-10.3 alt-ex103_261.htm EX-10.3 230402
4 EX-10.4 alt-ex104_262.htm EX-10.4 87114
5 EX-31.1 alt-ex311_8.htm EX-31.1 18179
6 EX-31.2 alt-ex312_9.htm EX-31.2 17912
7 EX-32.1 alt-ex321_7.htm EX-32.1 6196
8 EX-32.2 alt-ex322_10.htm EX-32.2 6161
  Complete submission text file 0001564590-19-043231.txt   6895100

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT alt-20190930.xml EX-101.INS 1198624
10 XBRL TAXONOMY EXTENSION SCHEMA alt-20190930.xsd EX-101.SCH 53170
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE alt-20190930_cal.xml EX-101.CAL 62054
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE alt-20190930_def.xml EX-101.DEF 181798
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE alt-20190930_lab.xml EX-101.LAB 431338
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE alt-20190930_pre.xml EX-101.PRE 315029
Mailing Address 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878
Business Address 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878 2406541450
Altimmune, Inc. (Filer) CIK: 0001326190 (see all company filings)

IRS No.: 202726770 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32587 | Film No.: 191214106
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences